Oral manifestations and their treatment in Sjögren's syndrome

Oral Diseases

Volumn 20, Issue 2, 2014, Pages 153-161

  Gonzalez S ^a   Sung, H ^b   Sepulveda D ^b   Gonzalez M J ^b   Molina, C ^a  

^a UNIVERSIDAD MAYOR   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Hyposalivation; Sj gren's syndrome; Xerostomia

Indexed keywords

COMPLICATION; DENTAL PLAQUE; HUMAN; MOUTH DISEASES; SJOEGREN SYNDROME;

DENTAL PLAQUE; HUMANS; MOUTH DISEASES; SJOGREN'S SYNDROME;

EID: 84893810965     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12105     Document Type: Review

References (113)

1. Agrawal KK, Singh SV, Rashmikant US, Singh RD, Chand P (2011). Prosthodontic rehabilitation in Sjogren's syndrome with a simplified palatal reservoir: two year follow up. J Prosthodont Res 55: 248-251.
2. Albuquerque DF, de Souza Tolentino E, Amado FM, Arakawa C, Chinellato LE (2010). Evaluation of halitosis and sialometry in patients submitted to head and neck radiotherapy. Med Oral Patol Oral Cir Bucal 15: e850-e854.
3. Alliende C, Kwon YJ, Brito M et al (2008). Reduced sulfation of muc5b is linked to xerostomia in patients with Sjogren syndrome. Ann Rheum Dis 67: 1480-1487.
4. Almstah IA, Wikstrom M, Stenberg I, Jakobsson A, Fagerberg-Mohlin B (2003). Oral microbiota associated with hyposalivation of different origins. Oral Microbiol Immunol 18: 1-8.
5. Almstahl A, Kroneld U, Tarkowski A, Wikstrom M (1999). Oral microbial flora in Sjogren's syndrome. J Rheumatol 26: 110-114.
6. Almstahl A, Wikstrom M, Kroneld U (2001). Microflora in oral ecosystems in primary Sjogren's syndrome. J Rheumatol 28: 1007-1013.
7. Antoniazzi RP, Miranda LA, Zanatta FB et al (2009). Periodontal conditions of individuals with Sjogren's syndrome. J Periodontol 80: 429-435.
8. Atkinson JC, Grisius M, Massey W (2005). Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin North Am 49: 309-326.
9. Bahamondes V, Albornoz A, Aguilera S et al (2011). Changes in Rab3D expression and distribution in the acini of Sjogren's syndrome patients are associated with loss of cell polarity and secretory dysfunction. Arthritis Rheum 63: 3126-3135.
10. Bardow A, Nyvad B, Nauntofte B (2001). Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol 46: 413-423.
11. Bardow A, ten Cate JM, Nauntofte B, Nyvad B (2003). Effect of unstimulated saliva flow rate on experimental root caries. Caries Res 37: 232-236.
12. Barrera MJ, Sanchez M, Aguilera S et al (2012). Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjogren's syndrome patients is linked to ectopic mucin secretion. J Autoimmun 39: 83-92.
13. Baudet-Pommel M, Albuisson E, Kemeny JL et al (1994). Early dental loss in Sjogren's syndrome. Histologic correlates. European Community Study Group on Diagnostic Criteria for Sjogren's Syndrome (EEC COMAC). Oral Surg Oral Med Oral Pathol 78: 181-186.
14. Belenguer R, Ramos-Casals M, Brito-Zeron P et al (2005). Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjogren's syndrome. Clin Exp Rheumatol 23: 351-356.
15. Bergdahl M (2000). Salivary flow and oral complaints in adult dental patients. Commun Dent Oral Epidemiol 28: 59-66.
16. Bergdahl M, Bergdahl J (2000). Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 79: 1652-1658.
17. Bernardi G, Kawasaki T (1968). Chromatography of polypeptides and proteins on hydroxyapatite columns. Biochim Biophys Acta 160: 301-310.
18. Binon PP (2005). Thirteen-year follow-up of a mandibular implant-supported fixed complete denture in a patient with Sjogren's syndrome: a clinical report. J Prosthet Dent 94: 409-413.
19. Binon PP, Fowler CN (1993). Implant-supported fixed prosthesis treatment of a patient with Sjogren's syndrome: a clinical report. Int J Oral Maxillofac Implants 8: 54-58.
20. Boutsi EA, Paikos S, Dafni UG, Moutsopoulos HM, Skopouli FN (2000). Dental and periodontal status of Sjogren's syndrome. J Clin Periodontol 27: 231-235.
21. von Bultzingslowen I, Sollecito TP, Fox PC et al (2007). Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(Suppl): S57 e1-15.
22. Burt BA, Pai S (2001). Sugar consumption and caries risk: a systematic review. J Dent Educ 65: 1017-1023.
23. Carr AJ, Ng WF, Figueiredo F, Macleod RI, Greenwood M, Staines K (2012). Sjogren's syndrome - an update for dental practitioners. Br Dent J 213: 353-357.
24. Castro I, Sepulveda D, Cortes J et al (2012). Oral dryness in Sjogren's syndrome patients. Not just a question of water. Autoimmun Rev 12: 567-574.
25. Celenligil H, Eratalay K, Kansu E, Ebersole JL (1998). Periodontal status and serum antibody responses to oral microorganisms in Sjogren's syndrome. J Periodontol 69: 571-577.
26. Christensen LB, Petersen PE, Thorn JJ, Schiodt M (2001). Dental caries and dental health behavior of patients with primary Sjogren syndrome. Acta Odontol Scand 59: 116-120.
27. Cochrane NJ, Reynolds EC (2012). Calcium phosphopeptides - mechanisms of action and evidence for clinical efficacy. Adv Dent Res 24: 41-47.
28. Cury JA, Tenuta LM, Ribeiro CC, Paes Leme AF (2004). The importance of fluoride dentifrices to the current dental caries prevalence in Brazil. Braz Dent J 15: 167-174.
29. Cutress T, Howell PT, Finidori C, Abdullah F (1992). Caries preventive effect of high fluoride and xylitol containing dentifrices. ASDC J Dent Child 59: 313-318.
30. Dawes C (1987). Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 66 Spec No: 648-653.
31. Dawes C, Kubieniec K (2004). The effects of prolonged gum chewing on salivary flow rate and composition. Arch Oral Biol 49: 665-669.
32. Delaleu N, Nguyen CQ, Peck AB, Jonsson R (2011). Sjogren's syndrome: studying the disease in mice. Arthritis Res Ther 13: 217.
33. Dijkman A, Huizinga E, Ruben J, Arends J (1990). Remineralization of human enamel in situ after 3 months: the effect of not brushing versus the effect of an F dentifrice and an F-free dentifrice. Caries Res 24: 263-266.
34. Dodds MW, Hsieh SC, Johnson DA (1991). The effect of increased mastication by daily gum-chewing on salivary gland output and dental plaque acidogenicity. J Dent Res 70: 1474-1478.
35. Emilson CG (1977). Susceptibility of various microorganisms to chlorhexidine. Scand J Dent Res 85: 255-265.
36. Enger TB, Palm O, Garen T, Sandvik L, Jensen JL (2011). Oral distress in primary Sjogren's syndrome: implications for health-related quality of life. Eur J Oral Sci 119: 474-480.
37. Ergun S, Cekici A, Topcuoglu N et al (2010). Oral status and Candida colonization in patients with Sjogren's Syndrome. Med Oral Patol Oral Cir Bucal 15: e310-e315.
38. Ewert P, Aguilera S, Alliende C et al (2010). Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum 62: 1280-1289.
39. Featherstone JD (2000). The science and practice of caries prevention. J Am Dent Assoc 131: 887-899.
40. Feuerstein O (2012). Light therapy: complementary antibacterial treatment of oral biofilm. Adv Dent Res 24: 103-107.
41. Fife RS, Chase WF, Dore RK et al (2002). Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial. Arch Intern Med 162: 1293-1300.
42. Firestone AR, Muhlemann HR (1985). In vivo pH of plaque-covered and plaque-free interdental surfaces in humans following a sucrose rinse. Clin Prev Dent 7: 24-26.
43. Fox PC (2004). Salivary enhancement therapies. Caries Res 38: 241-246.
44. Fox RI, Stern M, Michelson P (2000). Update in Sjogren syndrome. Curr Opin Rheumatol 12: 391-398.
45. Frost PM, Shirlaw PJ, Challacombe SJ, Fernandes-Naglik L, Walter JD, Ide M (2006). Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients. Oral Dis 12: 57-62.
46. Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R (2011). Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev Issue 12. Art. No.: CD008934. DOI: 10.1002/14651858.CD008934.pub2.
47. Gonzalez S, Aguilera S, Alliende C et al (2011). Alterations in type I hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 63: 1106-1115.
48. Gustafsson BE, Quensel CE, Lanke LS et al (1954). The Vipeholm dental caries study; the effect of different levels of carbohydrate intake on caries activity in 436 individuals observed for five years. Acta Odontol Scand 11: 232-264.
49. Hannig M, Hannig C (2012). Nanotechnology and its role in caries therapy. Adv Dent Res 24: 53-57.
50. Hay KD, Thomson WM (2002). A clinical trial of the anticaries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93: 271-275.
51. van Houte J (1994). Role of micro-organisms in caries etiology. J Dent Res 73: 672-681.
52. Isidor F, Brondum K, Hansen HJ, Jensen J, Sindet-Pedersen S (1999). Outcome of treatment with implant-retained dental prostheses in patients with Sjogren syndrome. Int J Oral Maxillofac Implants 14: 736-743.
53. Jorkjend L, Johansson A, Johansson AK, Bergenholtz A (2003). Periodontitis, caries and salivary factors in Sjogren's syndrome patients compared to sex- and age-matched controls. J Oral Rehabil 30: 369-378.
54. Jorkjend L, Bergenholtz A, Johansson AK, Johansson A (2008). Effect of Pilocarpine on impaired salivary secretion in patients with Sjogren's syndrome. Swed Dent J 32: 49-56.
55. Kassan SS, Moutsopoulos HM (2004). Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164: 1275-1284.
56. Kolavic SA, Gibson G, al-Hashimi I, Guo IY (1997). The level of cariogenic micro-organisms in patients with Sjogren's syndrome. Spec Care Dentist 17: 65-69.
57. Kuru B, McCullough MJ, Yilmaz S, Porter SR (2002). Clinical and microbiological studies of periodontal disease in Sjogren syndrome patients. J Clin Periodontol 29: 92-102.
58. Lamanda A, Cheaib Z, Turgut MD, Lussi A (2007). Protein buffering in model systems and in whole human saliva. PLoS ONE 2: e263.
59. Leone CW, Oppenheim FG (2001). Physical and chemical aspects of saliva as indicators of risk for dental caries in humans. J Dent Educ 65: 1054-1062.
60. Leung KC, Leung WK, McMillan AS (2007). Supra-gingival microbiota in Sjogren's syndrome. Clin Oral Invest 11: 415-423.
61. Lingstrom P, van Houte J, Kashket S (2000). Food starches and dental caries. Crit Rev Oral Biol Med 11: 366-380.
62. Lopez-Jornet P, Camacho-Alonso F (2008). Quality of life in patients with Sjogren's syndrome and sicca complex. J Oral Rehabil 35: 875-881.
63. Lundstrom IM, Lindstrom FD (1995). Subjective and clinical oral symptoms in patients with primary Sjogren's syndrome. Clin Exp Rheumatol 13: 725-731.
64. Machiulskiene V, Nyvad B, Baelum V (2001). Caries preventive effect of sugar-substituted chewing gum. Commun Dent Oral Epidemiol 29: 278-288.
65. Manoussakis MN, Kapsogeorgou EK (2010). The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 35: 219-224.
66. Marsh PD (1994). Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res 8: 263-271.
67. Marsh PD, Keevil CW, McDermid AS, Williamson MI, Ellwood DC (1983). Inhibition by the antimicrobial agent chlorhexidine of acid production and sugar transport in oral streptococcal bacteria. Arch Oral Biol 28: 233-240.
68. Mathews SA, Kurien BT, Scofield RH (2008). Oral manifestations of Sjogren's syndrome. J Dent Res 87: 308-318.
69. Mathiesen AT, Ogaard B, Rolla G (1996). Oral hygiene as a variable in dental caries experience in 14-year-olds exposed to fluoride. Caries Res 30: 29-33.
70. Mavragani CP, Moutsopoulos HM (2010). The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 9: A305-A310.
71. McDonnell G, Russell AD (1999). Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12: 147-179.
72. Mese H, Matsuo R (2007). Salivary secretion, taste and hyposalivation. J Oral Rehabil 34: 711-723.
73. Moore PA, Guggenheimer J (2008). Medication-induced hyposalivation: etiology, diagnosis, and treatment. Compend Contin Educ Dent 29: 50-55.
74. Muhlemann HR, Schmid R, Noguchi T, Imfeld T, Hirsch RS (1977). Some dental effects of xylitol under laboratory and in vivo conditions. Caries Res 11: 263-276.
75. Mutlu S, Richards A, Maddison P, Porter S, Scully C (1993). Gingival and periodontal health in Sjogren's syndrome and other connective tissue diseases. Clin Exp Rheumatol 11: 95-96.
76. Najera MP, al-Hashimi I, Plemons JM et al (1997). Prevalence of periodontal disease in patients with Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83: 453-457.
77. Navazesh M (2011). Saliva in health and disease. J Calif Dent Assoc 39: 626-628.
78. Nederfors T (2000). Xerostomia and hyposalivation. Adv Dent Res 14: 48-56.
79. Nyvad B, Fejerskov O (1997). Assessing the stage of caries lesion activity on the basis of clinical and microbiological examination. Commun Dent Oral Epidemiol 25: 69-75.
80. Oczakir C, Balmer S, Mericske-Stern R (2005). Implant-prosthodontic treatment for special care patients: a case series study. Int J Prosthodont 18: 383-389.
81. Payne AG, Lownie JF, Van Der Linden WJ (1997). Implant-supported prostheses in patients with Sjogren's syndrome: a clinical report on three patients. Int J Oral Maxillofac Implants 12: 679-685.
82. Pedersen AM, Reibel J, Nauntofte B (1999). Primary Sjogren's syndrome (pSS): subjective symptoms and salivary findings. J Oral Pathol Med 28: 303-311.
83. Pedersen AM, Bardow A, Nauntofte B (2005). Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjogren's syndrome. BMC Clin Pathol 5: 4.
84. Perez P, Goicovich E, Alliende C et al (2000). Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 43: 2807-2817.
85. Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X (2012). Primary Sjogren syndrome. BMJ 344: e3821.
86. van der Reijden WA, Vissink A, Veerman EC, Amerongen AV (1999). Treatment of oral dryness related complaints (xerostomia) in Sjogren's syndrome. Ann Rheum Dis 58: 465-474.
87. Rhodus NL, Michalowicz BS (2005). Periodontal status and sulcular Candida albicans colonization in patients with primary Sjogren's Syndrome. Quintessence Int 36: 228-233.
88. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J (1997). Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren's syndrome. J Otolaryngol 26: 300-305.
89. Rostron J, Rogers S, Longman L, Kaney S, Field EA (2002). Health-related quality of life in patients with primary Sjogren's syndrome and xerostomia: a comparative study. Gerodontology 19: 53-59.
90. Schaeken MJ, Keltjens HM, Van Der Hoeven JS (1991). Effects of fluoride and chlorhexidine on the microflora of dental root surfaces and progression of root-surface caries. J Dent Res 70: 150-153.
91. Scheie AA, Eggen KH, Rolla G (1987). Glucosyltransferase activity in human in vivo formed enamel pellicle and in whole saliva. Scand J Dent Res 95: 212-215.
92. Scheinin A, Makinen KK, Tammisalo E, Rekola M (1975). Turku sugar studies XVIII. Incidence of dental caries in relation to 1-year consumption of xylitol chewing gum. Acta Odontol Scand 33: 269-278.
93. Schiodt M, Christensen LB, Petersen PE, Thorn JJ (2001). Periodontal disease in primary Sjogren's syndrome. Oral Dis 7: 106-108.
94. Shivakumar KM, Vidya SK, Chandu GN (2009). Dental caries vaccine. Indian J Dent Res 20: 99-106.
95. Sintes JL, Escalante C, Stewart B et al (1995). Enhanced anticaries efficacy of a 0.243% sodium fluoride/10% xylitol/silica dentifrice: 3-year clinical results. Am J Dent 8: 231-235.
96. Smidt D, Torpet LA, Nauntofte B, Heegaard KM, Pedersen AM (2010). Associations between labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Commun Dent Oral Epidemiol 38: 422-435.
97. Soderling EM (2009). Xylitol, mutans streptococci, and dental plaque. Adv Dent Res 21: 74-78.
98. Soderling E, Hirvonen A, Karjalainen S, Fontana M, Catt D, Seppa L (2011). The effect of xylitol on the composition of the oral flora: a pilot study. Eur J Dent 5: 24-31.
99. Sonju T, Rolla G (1973). Chemical analysis of the acquired pellicle formed in two hours on cleaned human teeth in vivo. Rate of formation and amino acid analysis. Caries Res 7: 30-38.
100. Soto-Rojas AE, Kraus A (2002). The oral side of Sjogren syndrome. Diagnosis and treatment. A review. Arch Med Res 33: 95-106.
101. Sreebny LM (1982). Sugar availability, sugar consumption and dental caries. Commun Dent Oral Epidemiol 10: 1-7.
102. Stewart CM, Berg KM, Cha S, Reeves WH (2008). Salivary dysfunction and quality of life in Sjogren syndrome: a critical oral-systemic connection. J Am Dent Assoc 139: 291-299; quiz 358-9.
103. Sugerman PB, Barber MT (2002). Patient selection for endosseous dental implants: oral and systemic considerations. Int J Oral Maxillofac Implants 17: 191-201.
104. Suzuki K, Matsumoto M, Nakashima M et al (2005). Effect of cevimeline on salivary components in patients with Sjogren syndrome. Pharmacology 74: 100-105.
105. Tapper-Jones L, Aldred M, Walker DM (1980). Prevalence and intraoral distribution of Candida albicans in Sjogren's syndrome. J Clin Pathol 33: 282-287.
106. Tervahartiala T, Ingman T, Sorsa T, Ding Y, Kangaspunta P, Konttinen YT (1995). Proteolytic enzymes as indicators of periodontal health in gingival crevicular fluid of patients with Sjogren's syndrome. Eur J Oral Sci 103: 11-16.
107. Tschoppe P, Wolgin M, Pischon N, Kielbassa AM (2010). Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int 41: 321-333.
108. Tseng CC (1991). Periodontal status of patients with Sjogren's syndrome: a cross-sectional study. J Formos Med Assoc 90: 109-111.
109. Tseng CC, Wolff LF, Rhodus N, Aeppli DM (1990). The periodontal status of patients with Sjogren's syndrome. J Clin Periodontol 17: 329-330.
110. Turner RJ, Sugiya H (2002). Understanding salivary fluid and protein secretion. Oral Dis 8: 3-11.
111. Twetman S, Keller MK (2012). Probiotics for caries prevention and control. Adv Dent Res 24: 98-102.
112. Vitali C, Bombardieri S, Jonsson R et al (2002). Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
113. Vivino FB, Al-Hashimi I, Khan Z et al (1999). Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159: 174-181.